Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight
Indicators for the Metabolic Syndrome as Well as the Influence of Different Gen-polymorphs on Weightloss and the Maintenance of Lower Weight Among Children in Treatment for Overweight
Sponsor: Hagedorn Research Institute
Listed as NCT00823277, this observational or N/A phase trial focuses on Childhood Obesity and Hyperlipidemia and remains completed. Sponsored by Hagedorn Research Institute, it has been updated 14 times since 2009, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Aug 2023 — Jul 2024 [monthly]
Completed
-
Sep 2022 — Aug 2023 [monthly]
Completed
▶ Show 9 earlier versions
-
Dec 2021 — Sep 2022 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Aug 2020 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Aug 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hagedorn Research Institute
- Herlev Hospital
- Holbaek Sygehus
- The Novo Nordisk Foundation Center for Basic Metabolic Research
- University of Copenhagen
For direct contact, visit the study record on ClinicalTrials.gov .